https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=Palatin_Technologies_Inc%2C.Palatin Technologies Inc,. - Revizia istoricului2026-05-18T08:53:48ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=Palatin_Technologies_Inc,.&diff=437035&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei Palatin Technologies Inc,. listata cu simbolurile US.PTN, US.PTNc ==Descriere companie== Palatin Technologies, Inc. (https://www.palatin.com/), is a biopharmaceutical company. Palatin is focused on developing medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Palatin product candidates are targeted receptor-specific therapeutics for the treatment of diseases with unmet medical need a...2024-09-18T18:23:19Z<p>Pagină nouă: Pagina dedicata companiei Palatin Technologies Inc,. listata cu simbolurile US.PTN, US.PTNc ==Descriere companie== Palatin Technologies, Inc. (https://www.palatin.com/), is a biopharmaceutical company. Palatin is focused on developing medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Palatin product candidates are targeted receptor-specific therapeutics for the treatment of diseases with unmet medical need a...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei Palatin Technologies Inc,. listata cu simbolurile US.PTN, US.PTNc<br />
<br />
==Descriere companie==<br />
Palatin Technologies, Inc. (https://www.palatin.com/), is a biopharmaceutical company. Palatin is focused on developing medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Palatin product candidates are targeted receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. The melanocortin receptor (MCr) system has effects on food intake, metabolism, sexual function, inflammation, and immune system responses. The natriuretic peptide receptor (NPR) system regulates cardiovascular functions and tissue homeostasis, and therapeutic agents modulating this system have potential to treat cardiovascular and fibrotic diseases. Palatin lead product includes Vyleesi for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. Its other product line includes PL9643 for dry eye disease and anti-inflammatory ocular indications and Oral PL8177 for inflammatory bowel diseases.<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/US.PTN" /><br />
<iframe key="tradeville" path="graficSimbol/US.PTNc" /><br />
<br />
==Ultimele stiri despre Palatin Technologies Inc,. (US.PTN)==<br />
<dynamicpagelist><br />
category=US.PTN<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
==Ultimele stiri despre Palatin Technologies Inc,. (US.PTNc)==<br />
<dynamicpagelist><br />
category=US.PTNc<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:US.PTN]][[Categorie:US.PTNc]][[Categorie:Stiri despre companii]]</div>Admin